Browse

Poster Abstracts

D011

RETROAURICULAR THYROIDECTOMY WITH A NEXT-GENERATION SINGLE-PORT ROBOTIC SURGERY SYSTEM: PRECLINICAL STUDIES AND FIRST IN HUMAN CASE

Endocrine

Tyler Okland, MD1, Myung-Chul Lee, MD2, Kenric Tam, MD3, Estelle Chang, MD4, Eun Chang Choi, MD5, Floyd Christopher Holsinger, MD1, Yoon Woo Koh, MD5

1Stanford University, 2Korea Cancer Center Hospital, 3University of California -- Los Angeles School of Medicine, 4University of Nebraska, 5Yonsei University


D012

THYROID LOBECTOMY PROVIDES IMPROVED VALUE OVER TOTAL THYROIDECTOMY IN WELL-SELECTED PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CARCINOMA

Endocrine

Olivia Do, MS1, Andrew J Thomas, MD, Richard Cannon, MD, Jason Hunt, MD, Luke Buchmann, MD, Dev Abraham, MD, Marcus M Monroe, MD, FACS, Mia Hashibe, PhD

University of Utah School of Medicine


D013

UTILITY OF PRE-OPERATIVE LOCALIZATION STUDIES IN DIAGNOSING THE INTRA-THYROIDAL PARATHYROID ADENOMA

Endocrine

Julia Noel, MD1, Ida Solis, MD2, Ramin Saket, MD3, Peter Shen, MD3, Mark Mamlouk, MD3, Ryan Niederkohr, MD3, Sumeer Gupta2, Lisa Orloff, MD1, Michael Friduss, MD3

1Stanford University, 2Kaiser Permanente San Francisco, 3Kaiser Permanente Santa Clara


D014

THE SURGICAL MANAGEMENT OF RETROPHARYNGEAL LYMPH NODE METASTASIS IN DIFFERENTIATED THYROID CARCINOMA

Endocrine

Victoria Harries, MBBS, Marlena McGill, BS, Laura Y Wang, MBBS, MS, Ashok R Shaha, MD, Jatin P Shah, MD, Richard J Wong, MD, R M Tuttle, MD, Snehal Patel, MD, Ian Ganly, MD, PhD

Memorial Sloan Kettering Cancer Center


D015

PREDICTIVE MODELING OF OPERATIVE TIME WITH TRANSORAL ENDOSCOPIC THYROIDECTOMY VESTIBULAR APPROACH (TOETVA)

Endocrine

Christopher R Razavi, MD, Lena W Chen, BA, Rohit Ranganath, MD, Ralph P Tufano, MD, MBA, Jonathon O Russell, MD

Johns Hopkins Department of OHNS


D016

LYMPH NODE RATIO AND OVERALL SURVIVAL IN PAPILLARY THYROID CANCER

Endocrine

Blaine D Smith, MD, Samantha M Thomas, MS, Taofik Oyekunle, MS, Daniel J Rocke, MD, JD

Duke University Medical Center


D018

INVESTIGATING THE POTENTIAL ROLE OF ANTI-PD-L1 IMMUNOTHERAPY IN AGGRESSIVE PAPILLARY THYROID CARCINOMA

Endocrine

L Boven1, S Terhoeve1, A Gundale1, B Beatrous1, T Moore-Medlin1, J McLarty1, X Ma1, H Savage1, X Gu1, R Ranganath2, C Nathan1

1LSU Health, 2Johns Hopkins


D019

KI-67 AND CK-19 ARE INDEPENDENT PREDICTORS OF LOCOREGIONAL RECURRENCE IN PAPILLARY THYROID CARCINOMA

Endocrine

Luiz Paulo Kowalski, PhD, MD

A C Camargo Cancer Center, Sao Paulo, Brazil


D020

THE EVOLUTION OF PAPILLARY THYROID CANCER DURING PREGNANCY.

Endocrine

Sriram Navuluri, Christopher M Yao, MD, Justin Tran, Mark Zafereo, MD, FACS

University of Texas MD Anderson Cancer Center


D022

USE OF OUTCOMES DATA TO STANDARDIZE MANAGEMENT OF POSTOPERATIVE HYPOCALCEMIA AFTER HEAD AND NECK ENDOCRINE SURGERY

Endocrine

Marcus J Magister, MD, Thomas Fitzpatrick, BS, Joshua Waltonen, MD, Brittany Henderson, MD, Christopher A Sullivan, MD

Wake Forest Baptist Medical Center